MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 82 filers reported holding MARINUS PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $118,000 | +110.7% | 46,734 | +71.0% | 0.00% | – |
| Q1 2020 | $56,000 | -49.5% | 27,329 | -46.9% | 0.00% | – |
| Q4 2019 | $111,000 | +22.0% | 51,468 | -12.8% | 0.00% | – |
| Q3 2019 | $91,000 | -32.1% | 59,031 | +82.5% | 0.00% | – |
| Q2 2019 | $134,000 | +139.3% | 32,351 | +142.6% | 0.00% | – |
| Q1 2019 | $56,000 | -1.8% | 13,336 | -33.3% | 0.00% | – |
| Q4 2018 | $57,000 | -90.3% | 20,000 | -65.8% | 0.00% | – |
| Q3 2018 | $585,000 | +75.7% | 58,556 | +24.4% | 0.00% | – |
| Q2 2018 | $333,000 | +43.5% | 47,057 | -22.2% | 0.00% | – |
| Q1 2018 | $232,000 | – | 60,501 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,042,735 | $14,473,000 | 4.95% |
| VHCP Management III, LLC | 1,258,964 | $3,613,000 | 2.63% |
| Granite Point Capital Management, L.P. | 2,659,367 | $7,632,000 | 1.54% |
| Granite Point Capital Management, L.P. | 1,600,000 | $4,592,000 | 0.93% |
| VHCP Management II, LLC | 743,876 | $2,135,000 | 0.92% |
| Monashee Investment Management LLC | 250,000 | $718,000 | 0.49% |
| 683 Capital Management, LLC | 1,350,000 | $3,875,000 | 0.24% |
| CAXTON CORP | 61,443 | $176,000 | 0.21% |
| Tekla Capital Management LLC | 755,776 | $2,169,000 | 0.09% |
| Fosun International Ltd | 491,997 | $1,378,000 | 0.08% |